vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and CENTRUS ENERGY CORP (LEU). Click either name above to swap in a different company.

COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $146.2M, roughly 1.4× CENTRUS ENERGY CORP). On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -3.6%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $-58.0M). Over the past eight quarters, CENTRUS ENERGY CORP's revenue compounded faster (82.9% CAGR vs 19.1%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

Centrus Energy Corp. is an American company that supplies nuclear fuel for use in nuclear power plants and works to develop and deploy centrifuge technology to produce enriched uranium for commercial and government uses, including for national security.

COLL vs LEU — Head-to-Head

Bigger by revenue
COLL
COLL
1.4× larger
COLL
$205.4M
$146.2M
LEU
Growing faster (revenue YoY)
COLL
COLL
+16.5% gap
COLL
12.9%
-3.6%
LEU
More free cash flow
COLL
COLL
$180.4M more FCF
COLL
$122.4M
$-58.0M
LEU
Faster 2-yr revenue CAGR
LEU
LEU
Annualised
LEU
82.9%
19.1%
COLL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COLL
COLL
LEU
LEU
Revenue
$205.4M
$146.2M
Net Profit
$17.0M
Gross Margin
62.5%
23.9%
Operating Margin
29.6%
8.8%
Net Margin
8.3%
Revenue YoY
12.9%
-3.6%
Net Profit YoY
35.3%
EPS (diluted)
$0.48
$0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
LEU
LEU
Q4 25
$205.4M
$146.2M
Q3 25
$209.4M
$74.9M
Q2 25
$188.0M
$154.5M
Q1 25
$177.8M
$73.1M
Q4 24
$181.9M
$151.6M
Q3 24
$159.3M
$57.7M
Q2 24
$145.3M
$189.0M
Q1 24
$144.9M
$43.7M
Net Profit
COLL
COLL
LEU
LEU
Q4 25
$17.0M
Q3 25
$31.5M
$3.9M
Q2 25
$12.0M
$28.9M
Q1 25
$2.4M
$27.2M
Q4 24
$12.5M
Q3 24
$9.3M
$-5.0M
Q2 24
$19.6M
$30.6M
Q1 24
$27.7M
$-6.1M
Gross Margin
COLL
COLL
LEU
LEU
Q4 25
62.5%
23.9%
Q3 25
61.7%
-5.7%
Q2 25
57.7%
34.9%
Q1 25
54.8%
45.0%
Q4 24
54.0%
40.8%
Q3 24
60.8%
15.4%
Q2 24
62.5%
19.3%
Q1 24
63.1%
9.8%
Operating Margin
COLL
COLL
LEU
LEU
Q4 25
29.6%
8.8%
Q3 25
29.7%
-22.2%
Q2 25
18.7%
21.7%
Q1 25
12.2%
28.0%
Q4 24
20.9%
29.7%
Q3 24
21.9%
-13.2%
Q2 24
32.7%
11.2%
Q1 24
34.1%
-24.3%
Net Margin
COLL
COLL
LEU
LEU
Q4 25
8.3%
Q3 25
15.0%
5.2%
Q2 25
6.4%
18.7%
Q1 25
1.4%
37.2%
Q4 24
6.9%
Q3 24
5.9%
-8.7%
Q2 24
13.5%
16.2%
Q1 24
19.1%
-14.0%
EPS (diluted)
COLL
COLL
LEU
LEU
Q4 25
$0.48
$0.52
Q3 25
$0.84
$0.19
Q2 25
$0.34
$1.59
Q1 25
$0.07
$1.60
Q4 24
$0.36
$3.26
Q3 24
$0.27
$-0.30
Q2 24
$0.52
$1.89
Q1 24
$0.71
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
LEU
LEU
Cash + ST InvestmentsLiquidity on hand
$386.7M
$2.0B
Total DebtLower is stronger
$1.2B
Stockholders' EquityBook value
$301.7M
$765.1M
Total Assets
$1.7B
$2.4B
Debt / EquityLower = less leverage
1.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
LEU
LEU
Q4 25
$386.7M
$2.0B
Q3 25
$285.9M
$1.6B
Q2 25
$222.2M
$833.0M
Q1 25
$197.8M
$653.0M
Q4 24
$162.8M
$671.4M
Q3 24
$120.0M
$194.3M
Q2 24
$271.6M
$227.0M
Q1 24
$318.0M
$209.3M
Total Debt
COLL
COLL
LEU
LEU
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$390.0M
Q1 25
$389.5M
Q4 24
$472.5M
Q3 24
$83.5M
Q2 24
$86.5M
Q1 24
$86.5M
Stockholders' Equity
COLL
COLL
LEU
LEU
Q4 25
$301.7M
$765.1M
Q3 25
$274.8M
$363.1M
Q2 25
$232.2M
$359.1M
Q1 25
$234.4M
$213.9M
Q4 24
$228.8M
$161.4M
Q3 24
$234.3M
$76.4M
Q2 24
$216.6M
$76.6M
Q1 24
$222.2M
$33.8M
Total Assets
COLL
COLL
LEU
LEU
Q4 25
$1.7B
$2.4B
Q3 25
$1.6B
$2.2B
Q2 25
$1.6B
$1.3B
Q1 25
$1.6B
$1.3B
Q4 24
$1.7B
$1.1B
Q3 24
$1.6B
$591.0M
Q2 24
$1.1B
$668.2M
Q1 24
$1.1B
$750.0M
Debt / Equity
COLL
COLL
LEU
LEU
Q4 25
1.54×
Q3 25
3.23×
Q2 25
1.09×
Q1 25
1.82×
Q4 24
2.93×
Q3 24
1.09×
Q2 24
1.13×
Q1 24
2.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
LEU
LEU
Operating Cash FlowLast quarter
$123.0M
$-48.4M
Free Cash FlowOCF − Capex
$122.4M
$-58.0M
FCF MarginFCF / Revenue
59.6%
-39.7%
Capex IntensityCapex / Revenue
0.3%
6.6%
Cash ConversionOCF / Net Profit
7.25×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$31.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
LEU
LEU
Q4 25
$123.0M
$-48.4M
Q3 25
$78.4M
$10.1M
Q2 25
$72.4M
$52.8M
Q1 25
$55.4M
$36.5M
Q4 24
$84.6M
$57.9M
Q3 24
$-9.0M
$-33.2M
Q2 24
$67.4M
$7.0M
Q1 24
$61.9M
$5.3M
Free Cash Flow
COLL
COLL
LEU
LEU
Q4 25
$122.4M
$-58.0M
Q3 25
$78.3M
$5.7M
Q2 25
$72.4M
$49.2M
Q1 25
$54.6M
$34.4M
Q4 24
$84.1M
$57.2M
Q3 24
$-9.2M
$-34.2M
Q2 24
$67.1M
$6.1M
Q1 24
$61.4M
$3.8M
FCF Margin
COLL
COLL
LEU
LEU
Q4 25
59.6%
-39.7%
Q3 25
37.4%
7.6%
Q2 25
38.5%
31.8%
Q1 25
30.7%
47.1%
Q4 24
46.2%
37.7%
Q3 24
-5.8%
-59.3%
Q2 24
46.2%
3.2%
Q1 24
42.3%
8.7%
Capex Intensity
COLL
COLL
LEU
LEU
Q4 25
0.3%
6.6%
Q3 25
0.1%
5.9%
Q2 25
0.0%
2.3%
Q1 25
0.4%
2.9%
Q4 24
0.3%
0.5%
Q3 24
0.2%
1.7%
Q2 24
0.2%
0.5%
Q1 24
0.4%
3.4%
Cash Conversion
COLL
COLL
LEU
LEU
Q4 25
7.25×
Q3 25
2.49×
2.59×
Q2 25
6.05×
1.83×
Q1 25
22.92×
1.34×
Q4 24
6.75×
Q3 24
-0.96×
Q2 24
3.44×
0.23×
Q1 24
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

LEU
LEU

Separative Work Units$111.0M76%
Services$21.8M15%
Other$13.4M9%

Related Comparisons